Cisplatin resistance is associated with reduced interferon-γ-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells

Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

Tadashi Yamamoto, Shuntaro Ikawa, Tetsu Akiyama et al. · Nature · 1986 · 1.2K citations

Signal Transduction, Signaling Pathway, Human C-erb-b-2 Gene +8

Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.

Richard J. Pietras, B M Fendly, V R Chazin et al. · PubMed · 1994 · 438 citations

Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.

Andrews Pa, Howell Sb · PubMed · 1990 · 400 citations

Molecular Pharmacology, Tumor Biology, Chromatin +14

A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines.

M C Hancock, Tiffany Chan, Pam Toy et al. · PubMed · 1991 · 226 citations

Human Breast, C-erbb-2 Protein, Oncology +15

Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.

Éric Pujade-Lauraine, Jean‐Paul Guastalla, Nicoletta Colombo et al. · Journal of Clinical Oncology · 1996 · 160 citations